Regeneron Pharmaceuticals Inc. buy Evercore ISI
Start price
16.05.24
/
50%
€899.00
Target price
16.05.25
-
Performance (%)
-41.09%
End price
17.05.25
€529.60
Summary
This prediction ended on 17.05.25 with a price of €529.60. Massive losses of -41.09% were the result for the BUY prediction by Evercore_ISI. Evercore_ISI has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €0.84 are taken into consideration when calculating the performance. Evercore_ISI has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -0.787% | -0.787% | 17.068% |
| iShares Core DAX® | 1.163% | 3.678% | 4.548% |
| iShares Nasdaq 100 | 2.585% | 3.099% | 36.497% |
| iShares Nikkei 225® | 7.111% | 10.600% | 61.221% |
| iShares S&P 500 | 1.261% | 1.669% | 25.234% |
Comments by Evercore_ISI for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
Current prediction by Evercore_ISI for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€645.00
22.01.26
22.01.26
€748.48
22.01.27
22.01.27
-17.88%
20:43
20:43
Stopped prediction by Evercore_ISI for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€859.80
24.10.24
24.10.24
€1,087.7
24.10.25
24.10.25
-42.02%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€909.80
14.05.24
14.05.24
€1,064.2
14.05.25
14.05.25
-43.88%
15.05.25
15.05.25